Stryker announces Dr. Srikant Datar will retire from Board of Directors
06 Dezembro 2023 - 10:00AM
Stryker (NYSE:SYK) announced today that after 15 years of
distinguished service, Dr. Srikant Datar has notified the
Company that he will not stand for re-election at Stryker's 2024
Annual Meeting of Shareholders, which is expected to be held
on May 9, 2024.
Dr. Datar is the Dean of the Harvard Business School and George
F. Baker Professor of Business Administration. He was the Arthur
Lowes Dickinson Professor at the Graduate School of Business
Administration of Harvard University from 1996 to 2020 and is the
former Faculty Chair of the Harvard Innovation Labs and Senior
Associate Dean for University Affairs. From 1989 to 1996, Dr. Datar
was Edmund W. Littlefield Professor at the Graduate School of
Business, Stanford University. Dr. Datar is also a director of ICF
International, Inc., a management, technology and policy consulting
firm, and T-Mobile US, Inc., a provider of wireless voice,
messaging and data services. In 2020, he was recognized by the
National Association of Corporate Directors (NACD) as Public
Company Director of the Year.
Dr. Datar has an extensive background in accounting and finance
and a variety of other business areas, including performance
measurement, design thinking and innovation, and machine learning
and artificial intelligence. His strong academic and business
background and board experience for high tech global companies has
helped us accelerate our global growth through focus on organic and
M&A innovation.
“We sincerely appreciate Srikant’s many contributions to the
Board over the years and thank him for being a strategic resource
and champion of our growth ambitions,” said Kevin Lobo, Chair and
Chief Executive Officer. “We wish Srikant all the best and thank
him for his guidance in helping Stryker deliver on its mission of
making healthcare better.”
Stryker is one of the world’s leading medical technology
companies and, together with its customers, is driven to make
healthcare better. The company offers innovative products and
services in Medical and Surgical, Neurotechnology, Orthopaedics and
Spine that help improve patient and healthcare outcomes. Alongside
its customers around the world, Stryker impacts more than 130
million patients annually. More information is available at
www.stryker.com.
Contacts
For investor inquiries please contact:Jason
Beach, Vice President, Investor Relations at 269-385-2600 or
jason.beach@stryker.com
For media inquiries please contact:Yin Becker,
Vice President, Chief Corporate Affairs Officer at 269-385-2600 or
yin.becker@stryker.com
Stryker (NYSE:SYK)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Stryker (NYSE:SYK)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024